Sign up
Pharma Capital

AIM winner sees big European opportunities after Ecuphar deal

Christiaan Cardon, chief executive of Animalcare Group PLC (LON:ANCR) tells Proactive they're a growing business - developing, selling and marketing veterinary pharmaceuticals to niche markets.

Cardon says they want to become one of the leaders in Europe.

This year the group won the AIM Transaction of the Year Award following the acquisition of Ecuphar NV, a European animal health company that develops and sells veterinary pharmaceutical products.


View full ANCR profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.